L. Qiu

发表

Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis

Q. Wei, Meiling Zhu, D. Ye, 2013, Molecular Biology Reports.

A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer

Zhe Zhang, Yusheng Wang, Xiaodong Zhu, 2021, Asia-Pacific journal of clinical oncology.

XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)

Yi He, Wen-hua Li, J. Ying, 2022, Cancer communications.

Influence of hypoxia-related genetic polymorphisms on the prognosis of patients with metastatic gastric cancer treated with EOF.

Wenbo Tang, Xiaodong Zhu, Xin Liu, 2017, Oncology letters.

Novel functional variants in the Notch pathway and survival of Chinese colorectal cancer

Q. Wei, S. Cai, Lei Cheng, 2020, International journal of cancer.

mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers

Yan Zhou, H. Zhong, L. Xiong, 2022, Journal of translational medicine.

Oxidative Stress-Related Genetic Polymorphisms Are Associated with the Prognosis of Metastatic Gastric Cancer Patients Treated with Epirubicin, Oxaliplatin and 5-Fluorouracil Combination Chemotherapy

Weijian Guo, Xiaodong Zhu, Xin Liu, 2014, PloS one.

Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer

Wen-hua Li, Xiaodong Zhu, Xin Liu, 2022, Frontiers in Oncology.

A phase II study of irinotecan as single agent in the third-line treatment of unresectable or metastatic gastric cancer.

Xiao-dong Zhu, Zhe Zhang, Weijian Guo, 2018 .

Role of Epidermal Growth Factor Receptor Expression on Patient Survival in Pancreatic Cancer: A Meta-Analysis

Jiang Long, Jin Xu, Chen Liu, 2011, Pancreatology.

Contents Vol. 11, 2011

E. Achten, J. Neoptolemos, D. Yadav, 2012, Pancreatology.

mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers

Yan Zhou, H. Zhong, L. Xiong, 2022, Journal of translational medicine.

Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy

Weijian Guo, Xiaodong Zhu, Xin Liu, 2016, Tumor Biology.

Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression

Menghong Sun, Q. Wei, Lei Cheng, 2017, Molecular carcinogenesis.

Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma

Huanming Yang, Jun Wang, Mingbang Wang, 2015, Scientific Reports.

Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 Polymorphisms Are Associated with Decreased Risk of Esophageal Squamous Cell Carcinoma in Chinese Populations

Q. Wei, Ya-jun Yang, Jiucun Wang, 2014, PloS one.

Dynamic monitoring of HER2 amplification in circulating DNA of patients with metastatic colorectal cancer treated with cetuximab

W. Li, L. Qiu, Wei Li, 2019, Clinical and Translational Oncology.

The FAS ligand promoter polymorphism, rs763110 (−844C>T), contributes to cancer susceptibility: evidence from 19 case–control studies

Meilin Wang, Zhengdong Zhang, Zhizhong Zhang, 2009, European Journal of Human Genetics.

Maintenance treatment of Uracil and Tegafur (UFT) in responders following first-line fluorouracil-based chemotherapy in metastatic gastric cancer: a randomized phase II study

Xiaodong Zhu, Xin Liu, Xin-min Zhao, 2016, Oncotarget.

Potentially Functional Variants of PLCE1 Identified by GWASs Contribute to Gastric Adenocarcinoma Susceptibility in an Eastern Chinese Population

Menghong Sun, Q. Wei, Hongxia Ma, 2012, PloS one.

Predictive model for risk of gastric cancer using genetic variants from genome‐wide association studies and high‐evidence meta‐analysis

Menghong Sun, Ya-jun Yang, Jing He, 2020, Cancer medicine.

miR-449b rs10061133 and miR-4293 rs12220909 polymorphisms are associated with decreased esophageal squamous cell carcinoma in a Chinese population

Q. Wei, Shicheng Guo, Ya-jun Yang, 2015, Tumor Biology.

Association between Fc receptor-like 3 C169T polymorphism and risk of systemic lupus erythematosus: a meta-analysis

D. Ye, C. Mao, Qing Chen, 2009, Molecular Biology Reports.

FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial

Jianfeng Luo, Zhe Zhang, Yusheng Wang, 2022, Therapeutic advances in medical oncology.

Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients

Menghong Sun, Q. Wei, Lei Cheng, 2018, International journal of cancer.

Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis

Q. Wei, Meiling Zhu, D. Ye, 2012, Molecular Biology Reports.

Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases

Xinxiang Li, Sijie Sun, Xiaodong Zhu, 2022, Frontiers in Oncology.

Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer

Guangyu Liu, Z. Shao, Si Sun, 2014, International journal of nanomedicine.

Comparison of intravoxel incoherent motion imaging, diffusion kurtosis imaging, and conventional DWI in predicting the chemotherapeutic response of colorectal liver metastases.

R. Grimm, C. Fu, T. Tong, 2020, European journal of radiology.

Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trial

S. Zhang, F. Lv, Weijian Guo, 2015, Cancer Chemotherapy and Pharmacology.

Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy

Q. Wei, Meiling Zhu, J. Xiang, 2016, Journal of Translational Medicine.

Functional variation of SLC52A3 rs13042395 predicts survival of Chinese gastric cancer patients

Lei Cheng, L. Qiu, Liqin Zhao, 2020, Journal of cellular and molecular medicine.

Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial

Zhe Zhang, Lei Yang, Xiaodong Zhu, 2023, Cancer biology & medicine.